MDT

Medtronic plc

October 12, 2026 · pre-market

Rarity

1.27

Peak move

+4.72%

Float cap

$113.2B

Medtronic plc is a global medical technology company that develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, and patients. Its product portfolio spans cardiovascular rhythm and heart failure devices, structural heart and aortic valves, and medical-surgical equipment across neuroscience and surgical care. Medtronic operates in more than 150 countries.

• Timed with the movespinoff_divestitureOct 12 · 08:45 ET

  Medtronic's MiniMed Group split-off exchange offer, which expired Oct 9, 2026, was oversubscribed: 298,024,452 Medtronic ordinary shares were tendered and it will accept 55,032,401 in exchange for all 252,813,348 MiniMed shares it held at a 4.5939 ratio, about 18.3% proration; MiniMed now trades on Nasdaq as MMED.

  wireprnewswire.comWebdigital-release.kxan.comWebnews.medtronic.comWebnews.medtronic.com
• analyst_ratingOct 12

  BTIG maintained a Buy rating on Medtronic but lowered its price target to $99 from $100 as part of a research note previewing Q3 MedTech results.

  Webtipranks.comWebgurufocus.com
• regulatory_approvalOct 10 · 01:05 ET

  Medtronic received FDA 510(k) clearance for its navigated ApexCut EM blades for sinus surgery, which connect to its Stealth AXiS ENT navigation system, with first US clinical use planned for later in 2026 after a software release.

  Webboerse-global.de
• executive_appointmentOct 7

  Medtronic named Felicia Kurz as Vice President and General Manager of its Cardiac Ablation Solutions business as it pushes to grow electrophysiology therapies including pulsed field ablation devices.

  Webmedtechdive.com
• analyst_ratingOct 7

  Barclays initiated coverage on Medtronic with an Equal-Weight rating and a $95.00 price target, announced by analyst Christopher Pasquale.

  Webgurufocus.com
• product_delay_recallSep 15 · 06:19 ET

  The FDA classified as Class I the recall of Medtronic and subsidiary Given Imaging's Bravo CF esophageal pH monitoring capsule delivery devices (FGS-0635, FGS-0636) over capsule attachment/detachment failures, with 184 serious injuries and no deaths reported as of Aug 10, 2026.

  Webfda.gov